Incyte Discloses Promising New Data in Combo Drug Trial With Merck & Co.'s Keytruda Post author:Sam Post published:August 30, 2017 Post category:BioPharma August 31, 2017By Mark Terry… Source: BioSpace You Might Also Like Tandem Diabetes Care Reports Second Quarter 2017 Financial Results July 27, 2017 Keystone Heart to Accelerate Trials for a New Advanced Cerebral Embolic Protection Device August 1, 2017 Seattle's Genoa Pharma Banks $62 Million and Names a New CEO and CSO May 14, 2017
Keystone Heart to Accelerate Trials for a New Advanced Cerebral Embolic Protection Device August 1, 2017